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Murine natural killer (NK) cells are regulated by the interac-
tion of Ly49 receptors with major histocompatibility complex
class I molecules (MHC-I). Although the ligands for inhibitory
Ly49 were considered to be restricted to classical MHC (MHC-
Ia), we have shown that the non-classicalMHCmolecule (MHC-
Ib)H2-M3was a ligand for the inhibitory Ly49A.Herewe estab-
lish that another MHC-Ib, H2-Q10, is a bona fide ligand for the
inhibitory Ly49C receptor. H2-Q10 bound to Ly49Cwith amar-
ginally lower affinity (5 M) than that observed between
Ly49C and MHC-Ia (H-2Kb/H-2Dd, both1 M), and this rec-
ognition could be prevented by cis interactions with H-2K in
situ. To understand the molecular details underpinning Ly49
MHC-Ib recognition, we determined the crystal structures of
H2-Q10 and Ly49C bound H2-Q10. Unliganded H2-Q10
adopted a classicalMHC-I fold and possessed a peptide-binding
groove that exhibited features similar to those found inMHC-Ia,
explaining the diverse peptide binding repertoire of H2-Q10.
Ly49C bound to H2-Q10 underneath the peptide binding plat-
form to a region that encompassed residues from the1,2, and
3 domains, as well as the associated2-microglobulin subunit.
This dockingmodewas conservedwith that previously observed
for Ly49CH-2Kb. Indeed, structure-guided mutation of Ly49C
indicated that Ly49CH2-Q10 and Ly49CH-2Kb possess similar
energetic footprints focused around residues located within the
Ly49C4-stand and L5 loop, which contact the underside of the
peptide-binding platform floor. Our data provide a structural
basis for Ly49MHC-Ib recognition and demonstrate that
MHC-Ib represent an extended family of ligands for Ly49
molecules.
The primary function of major histocompatibility complex
class I molecules (MHC-I)5 is to capture peptides derived from
self- and pathogen-derived proteins to display them on the cell
surface for immune surveillance byCD8Tcells. There are two
broad types ofMHC-I. “Classical” or “class Ia”MHC (MHC-Ia)
are ubiquitously expressed on all nucleated cells and are highly
polymorphic in nature, thereby allowing them to present a
diverse array of peptides to CD8 T cells and ensure immunity
to a wide range of infections (1). In addition to the polymorphic
MHC class Ia molecules, the MHC gene cluster also encodes
a number of “non-classical” or “class Ib” MHC molecules
(MHC-Ib). MHC-Ib share structural similarity with their
MHC-Ia counterparts, but have limited polymorphism and
often display a tissue-specific pattern of expression (2). In
contrast to humans, where MHC-Ib are limited to three genes
encoding HLA-E, HLA-F, and HLA-G, MHC-Ib genes in mice
are highly divergent, with most mouse strains encoding dozens
of genes in the H2-Q, H2-T, and H2-M regions (3). However,
the function of many of the murineMHC-Ib currently remains
unknown.
In addition to their role in activating CD8 T cells, MHC-Ia
also serve as ligands for receptor families that regulate the func-
tion of natural killer (NK) cells. For example, groups of HLA-B
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and HLA-C alleles in humans are recognized by inhibitory
KIR3DL1 and KIR2DL1/2/3, respectively (4). Down-regulation
of surface MHC-Ia, as may occur during viral infection or fol-
lowing malignant transformation, results in a loss of inhibitory
signals and can trigger NK cell activation, a process termed
“missing-self” (5). Furthermore, recognition of self-MHC-Ia by
inhibitory KIR also plays a key role in the generation of NK cells
capable of responding to cells that lack MHC-Ia. Indeed, NK
cells expressing inhibitory receptors that have specificity for
self-MHC-I proteins have elevated responses to MHC-I-defi-
cient target cells when compared with those that lack such
receptors, a process called licensing (6).
The functional homologue of KIR in mice is the Ly49 family
of NK cell receptors. Like KIR, the highly polymorphic Ly49
family of ligands encodes for both activating and inhibitory iso-
forms that recognize MHC-I or MHC-I-like ligands (7). Also
similar to KIR, the established ligands for the Ly49 family are
composed of MHC-Ia. These interactions include recognition
of H-2Dd by Ly49A, H-2Dk by Ly49G, and H-2Kb by Ly49C (8,
9). The ternary structures of H-2DdLy49A and H-2KbLy49C
have been solved, providingmolecular details of the interaction
between Ly49 and MHC-Ia. Although the human KIR recep-
tors bind over the 1 and 2 helices of theMHC-Ia, positioned
over the C-terminal end of the peptide (10, 11), the Ly49
MHC-Ia crystal structures revealed a completely different
mode of recognition. In both the Ly49AH-2Dd and the
Ly49CH-2Kb structures, the Ly49 was bound to a concave
groove underneath the peptide-binding platform (12), a loca-
tion that precludes any direct contact with the peptide.
Although the overall docking mode was conserved, the
Ly49AH-2Dd and Ly49CH-2Kb structures did differ in the
configuration of the Ly49 homo-dimer and the stoichiometry
of the Ly49MHC-Ia complex. These differences likely relate to
the capacity of Ly49 to recognizeMHC-Iwithin the plane of the
same membrane (in cis) and also on opposing cell membranes
(in trans). Although cis interactions do not lead to productive
signaling, they are proposed to restrict NK inhibition, thus
facilitating NK effector functions (13).
MHC-Ib in humans and mice can perform specialized func-
tions, including in the regulation of NK cells. Mouse Qa-1b and
its human homologue, HLA-E, play a dual role in immunity by
presenting peptides to receptors expressed on NK cells as well
as to the T cell receptor of CD8 cells (14). In humans, the
MHC-Ib HLA-G exhibits a highly restricted pattern of tissue
expression, largely limited to developing trophoblast cells in the
placenta (15, 16). Hence HLA-G has been proposed to play a
specialized role in the maintenance of pregnancy by modulat-
ing leukocyte function, acting as a ligand for receptors of the
leukocyte immunoglobulin-like receptor (LILR) and/or KIR
receptor families (17). Furthermore, some HLA-G isoforms
include secreted forms of the molecule (sHLA-G). In addition
to the role that sHLA-Gmight play in the regulation of NK cell
function (18), it has also been shown to modulate chemokine
receptor expression on certainCD4 andCD8T cell populations
(19).
Although a direct homologue of HLA-G has yet to be con-
firmed inmice, themurineMHC-IbH2-Q10 is the onlymurine
MHC-I found in the serum in appreciable concentrations (20).
H2-Q10 has a truncation in the C terminus and the presence of
several substitutions in the transmembrane region that are
responsible for the soluble nature of this protein. Like
HLA-G, H2-Q10 also shows a restricted pattern of expres-
sion, being overexpressed in the liver when compared with
other tissues (21). In addition, both H2-Q10 (22) and HLA-G
(23) have a more diverse peptide binding repertoire than
many other MHC-Ib such as Qa-1b, HLA-E, and H2-M3,
where the peptide binding repertoires are highly restricted
(22). These factors suggest that H2-Q10 may play a highly
specialized role in immunity, yet its precise function cur-
rently remains unknown.
It was recently demonstrated that the MHC-Ib, H2-M3, is a
functional, high affinity ligand for Ly49A (24). Moreover,
H2-M3 played a role in licensing Ly49A-expressing NK cells.
This provided the first evidence that MHC-Ib could act as
ligands for Ly49 family members. However, whether additional
Ly49 ligands exist within the MHC-Ib family, as well as the
molecular basis underpinning these interactions, remains
unclear. Here, we demonstrate that H2-Q10 is a bona fide
ligand for Ly49C. Furthermore, we report the first crystal struc-
tures of H2-Q10 and the Ly49CH2-Q10 complex. H2-Q10 has
a structural and energetic footprint on Ly49C that overlaps sig-
nificantly with that of H-2Kb. These results extend the known
ligands for Ly49 receptors and suggest that the family of
MHC-Ib play an important role in the shaping of NK cell
responses.
Results
H2-Q10 Binds Specifically to Ly49C—Alignment of the
sequence of the H2-Q10 heavy chain with classical MHC-en-
coded heavy chains identified regions of sequence homology
between H2-Q10 (National Center for Biotechnology Informa-
tion (NCBI) accession codeAAH11215.1), H-2Kb (NCBI acces-
sion code 1VAC_A) andH-2Dd (NCBI accession code 1BII_A),
both of which are known ligands for Ly49C (Fig. 1A). This
prompted us to determine whether H2-Q10 could also act as a
ligand for Ly49C. Initially, the binding of H2-Q10 tetramers
loaded with peptides derived from either T cell receptor (TCR)
V chain (TGTETLYF) or ribophorin (VGITNVDL) to a panel
of CHO cells expressing Ly49CB6, Ly49HB6, and Ly49IB6 was
assessed. Among these closely related Ly49molecules, H2-Q10
bound to Ly49C, but not Ly49H or Ly49I, in a manner that was
independent of the sequence of the bound peptide (Fig. 1B). In
contrast, Qa-1b did not bind appreciably to any of the Ly49-
expressing cells. These data provide the first evidence that
Ly49C is able to specifically recognize H2-Q10.
cis Interactions with H-2K Prevent H2-Q10 Binding to
Ly49C—In addition to recognizing H-2Kb in trans (on an
opposing cell membrane), Ly49C is known to interact with
H-2Kb through cis interactions (9). This cis binding can alter
the threshold forNK cell activation bymaking inhibitory recep-
tors unavailable for binding and may also be important in the
education of murine NK cells (25). We next sought to deter-
mine whether H2-Q10 binding to Ly49C could be regulated by
H-2Kmolecules expressed on the surface ofNKcells fromwild-
type mice where cis interactions are present or H-2KbDb-defi-
cient mice in which cis interactions with MHC-I are largely
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absent. Although we were unable to detect binding of H2-Q10
tetramers toNKcells fromwild-typemice, a significant propor-
tion of NK cells isolated from H-2Kb/Db-deficient mice was
stained by H2-Q10 tetramers (Fig. 1C). Similar to the results
obtained for CHO cells (Fig. 1B), both tetramers yielded similar
results irrespective of differences in the peptide sequence.
These results demonstrate that cis interaction of Ly49C with
H-2K molecules prevents recognition of H2-Q10 tetramers in
trans.
H2-Q10 Binds Ly49C but Not Ly49A—Given the inability of
tetrameric forms H2-Q10 to effectively compete with Ly49C
ligands bound in cis, we sought to determine the affinity of the
Ly49CH2-Q10 interaction using SPR. As positive controls, we
included known Ly49C ligands H-2Kb-SIINFEKL and H-2Dd-
AGPARAAAL, both of which bound to Ly49C with high affin-
ity (1.0 0.2 and 1.4 0.5M, respectively, Fig. 1D). Using the
same conditions, H2-Q10 also bound Ly49C, albeit with
slightly weaker affinity (5.0 0.5 M). As a further control, we
also assessed the binding of Ly49A to the various MHC-I.
Although Ly49A bound to H-2Dd with high affinity (0.5  0.1
M, Fig. 1D) in line with previously reported data (43), it did not
bind to either H-2Kb or H2-Q10. Moreover, neither Ly49A nor
Ly49C bound appreciably to the humanMHCclass Ibmolecule
HLA-E (Fig. 1). Overall, these data indicate that the Ly49CH2-
Q10 interaction is well within the range typically observed for
Ly49 receptors interacting with class Ia MHC.
Structure of Unliganded H2-Q10—To understand the struc-
tural basis for Ly49-mediated recognition of H2-Q10, we firstly
determined the structure of H2-Q10 presenting a ribophorin-
derived peptide (VGITNVDL) to 2.3 Å resolution (Table 1).
Despite reports that it is detectable in the serum as a multiva-
lent complex of 200–300 kDa (20, 26), H2-Q10-VGITNVDL
eluted as a monomer during size-exclusion chromatography
(not shown) and the crystal packing was not suggestive of
FIGURE 1.H2-Q10 is a bone-fide ligand for C57BL/6 Ly49C. A, sequence alignment of H2-Q10, H-2Kb, H-2Dd, and Qa-1b. Residues conserved in at least three
of the sequences are shown as dots. Binding sites for Ly49C on H-2Kb are shown within boxes. B, tetramer staining of CHO cells expressing Ly49C, Ly49H, and
Ly49I.Open curves show stainingwith Ly49-specific antibody (Anti Ly49), H2-Q10 loadedwith TGTETLYF (H2-Q10 TGT), H2-Q10 loadedwith VGITNVDL (H2-Q10
VGI), or Qa-1b loaded with AMAPRTLLL (Qa-1b QDM); black filled curves show isotype control antibody (for anti-Ly49) or irrelevant human HLA-E tetramer (for
H2-Q10). Data are representative of at least 5 independent experiments. C, H2-Q10 binding to Ly49C ex vivo is impaired by cis interactions with MHC-I.
Splenocytes were prepared fromWT and H-2Kb/Db double-deficient mice. Cells were stained with NK1.1, CD3, an irrelevant human HLA-E tetramer (control),
H2-Q10 tetramer loadedwith TGTETLYF (H2-Q10 TGT), or H2-Q10 loadedwith VGITNVDL (H2-Q10 VGI). The dot plots showevents that have been electronically
gated as singlets, live and CD3 (not shown), and presented as NK1.1 (vertical) versus tetramer (horizontal). Numbers in the top right quadrant of the H2-Q10-
stained panels represent the percentage of H2-Q10 NK cells and are presented as mean  S.E. of four mice. Data are representative of 2 independent
experiments using four mice per experiment (n 8).D, Ly49C binds with similar affinity to H2-Q10, H-2Kb, and H-2Dd. Binding decreasing concentrations (30,
12, 4.8, 1.92, 0.77 M; solid lines top to bottom) of Ly49C (upper) or Ly49A (lower) to streptavidin-immobilized H2-Q10-TGTETLYF, H-2Kb-SIINFEKL, H-2Dd-
AGPARAAAL, orHLA-E-VMAPRTLIL is shown. Results are presented in responseunits (RU) after subtractionof thebaseline values. Solid vertical lines at 0 and60 s
indicate injection start and stop, respectively. Binding affinity (determined by equilibrium analysis): H2-Q10-TGTETLYF-Ly49C KD  5.0  0.5 M; H-2K
b-
SIINFEKL-Ly49C, KD 1.0 0.2M; H2-D
d-AGAPARAAAL-Ly49C, KD 1.3 0.5M; H2-D
d-AGAPARAAAL-Ly49A KD 0.5 0.1M. Responses for HLA-E with
Ly49A and Ly49C, H2-Q10 with Ly49A, and H-2Kb with Ly49A are below the limit of detection.
Ly49C Recognizes the Non-classical MHCH2-Q10
18742 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 291•NUMBER 36•SEPTEMBER 2, 2016
 at CA
RD
IFF U
N
IV
ERSITY
 on June 12, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
higher order assemblies. The overall structure of H2-Q10 is
similar to other MHC-Ia and MHC-Ib, comprising a heavy
chain of 1, 2, and 3 domains that is non-covalently associ-
ated with a 2M subunit (Fig. 2A). The root mean square devi-
ation (r.m.s.d) between H2-Q10 and H-2Kb, HLA-A2, H2-M3,
and HLA-G was 1.87, 0.94, 0.77, and 1.02 Å over all C atoms,
respectively, further highlighting the high degree of structural
conservation between these related molecules.
The H2-Q10 peptide-binding groove is formed by an antipa-
rallel -sheet floor flanked by 1 and 2 helices, and is lined
with a myriad of aromatic side chains that support the
VGITNVDLpeptide in an extended conformation (Fig. 2,B and
C). Previous peptide elution and substitution experiments have
identified that H2-Q10 binds a heterogeneous repertoire of
peptides with a preference for Gly at P2, Leu/Val at P6, and
Phe/Leu at P (22). Accordingly, the H2-Q10 peptide-binding
groove is considered to resemble that of MHC-Ia rather than
those of other more specialized MHC-Ib such as Qa-1b (27),
H2-M3 (28), or HLA-E (29, 30). Overall, the unliganded
H2-Q10 structure supports this proposition. For example, the
main chain amine and carboxyl groups of P1-Val are hydrogen-
bonded to the side chains of Tyr-171 and Tyr-159 (Fig. 2,C and
D). These interactions are conserved in MHC-Ia structures
(31). Moreover, the C terminus of P8-Leu is similarly tethered
by hydrogen bonds to Tyr-84 and Thr-143, and is tightly
enshrined by Thr-143 and Trp-147, a feature of MHC-Ia that
directly contrasts to the looser fit of P observed in other
MHC-Ib including Qa-1 and HLA-E (Fig. 2, C–E) (27, 29). In
addition to the hydrogen bonding of the peptide termini,
H2-Q10 has five hydrophobic pockets that serve to anchor the
peptide at P2-Gly, P3-Ile, P5-Asn, P6-Val, and P8-Leu (Fig. 2,D
and E). Although the F pocket is deep to accommodate the Leu
or Phe residues that are favored by H2-Q10 at P, the remain-
der of the peptide-binding pockets are relatively shallow (Fig.
2E). In particular, the B pocket is particularly small, consisting
of a high “floor” provided by Tyr-7 and narrow “walls” formed
by Arg-66 and Tyr-159. Together, these residues dictate the
absolute requirement for a Gly residue at P2 (22). The C and E
pockets are similarly shallow, but relativelywide, thereby allow-
ing P3-Ile and P6-Val to point laterally to the side of the groove.
With the exception of P8-Leu, the only other peptide side chain
residue that points directly into the H2-Q10 groove is P5-Asn,
which makes extensive van derWaals interactions with Trp-97
and Phe-74, as well as hydrogen bonds to Ser-73 and Tyr-116
(Fig. 2, D and E). The extent of these interactions is somewhat
surprising, because peptide elution studies suggest that
H2-Q10 can accommodate a variety of amino acids at this posi-
tion (22). In addition to these anchor residues, positions
P4-Thr, P6-Val and P7-Asp are solvent-exposed and thus may
represent candidate T cell receptor contact sites.
Overview of the Ly49CH2-Q10 Structure—Next we deter-
mined the structure of H2-Q10-VGITNVDL bound to the lec-
tin domain of Ly49CB6 to 3.3 Å resolution. The structure
refined well, to an Rfactor and Rfree of 22.9 and 26.6%, respec-
tively, and the electron density at the Ly49Q10 interface was,
for the most part, unambiguous (Fig. 3A), permitting a detailed
understanding of the molecular interactions that underpin
Ly49CH2-Q10 recognition. During gel filtration chromatogra-
phy, Ly49C eluted at a position consistent with a dimer (not
shown), and in the crystal structure, two Ly49C lectin domains
were related by non-crystallographic symmetry to form a
homo-dimer.Our observation that Ly49C forms a homo-dimer
is in line with previous studies regarding the oligomeric status
of this receptor both in solution (32) and on the cell surface (33).
In the structure, each of the Ly49 lectin domains engaged
H2-Q10 via a concave surface underneath the peptide-binding
platform that encompassed the1,2,3, and2Msubunits of
the MHC-Ib (Fig. 3B). Accordingly, the entire complex com-
prised one Ly49 dimer bound to two H2-Q10 molecules in a
butterfly arrangement that is reminiscent of the Ly49CH-2Kb
structure (32) (Fig. 3B). As observed in previous Ly49MHC-Ia
structures, the receptor does not make any direct contacts with
the bound peptide (12, 32).
Variable Ly49 Configuration—Ly49 receptors can adopt
markedly different configurations to recognize MHC-I within
the plane of the samemembrane (in cis) or on opposing cells (in
trans) (33). To recognize MHC-I in trans, Ly49 molecules have
adopted an “open” conformation whereby the 2 helices are
splayed apart in a configuration that allows the Ly49 stalks to
backfold and interject the Ly49 homo-dimer interface, thereby
orienting the lectin domains in a manner that enables simulta-
neous recognition of two MHC-I (as observed for Ly49C-me-
diated recognition ofH-2Kb). However, in the “closed” cis bind-
ing conformation (as observed in the Ly49AH-2Dd structure),
the Ly49 monomers are tightly juxtaposed in a manner that
precludes simultaneous engagement of twoMHC-I ligands due
to steric clashes.Within the Ly49CH2-Q10 structure, the Ly49
homo-dimermost closely resembles the open conformation, in
that the 2 helices are separated by a gap of11.5 Å (Fig. 4A).
TABLE 1
Data collection and refinement statistics
Ly49C-Q10 Q10
Data collection statistics
Temperature (K) 100 100
X-ray source MX2 Australian
Synchrotron
MX1 Australian
Synchrotron
Space group I2 P212121
Cell dimensions
a, b, c (Å) 101.0, 57.8, 210.7 55.4, 81.7, 97.9
, ,  (°) 90.0, 96.15, 90.0 90, 90, 90
Resolution (Å) 60.45–3.3 (3.56–3.3) 42.0–2.3 (2.42–2.3)
Total no. of observations 64879 (13432) 136962 (19918)
No. of unique observations 18565 (3785) 20349 (2894)
Multiplicity 3.5 (3.5) 6.7 (6.9)
Data completeness (%) 99.9 (100) 99.8 (99.6)
I/I 5.8 (2.1) 6.6 (2.2)
Rmergea (%) 27.3 (69.1) 24.1 (95.3)
Rpim (%) 21.0 (52.1) 9.2 (36.0)
Refinement statistics
Non-hydrogen atoms
Protein 7879 3126
Water 0 136
Sugar 0 0
Rfactorb (%) 19.6 17.7
Rfree (%) 25.7 24.7
r.m.s.d from ideality
Bond lengths (Å) 0.009 0.01
Bond angles (°) 1.05 1.09
Ramachandran plot
Favored regions (%) 92.8 96.8
Allowed regions (%) 6.2 2.9
Disallowed regions (%) 1.0 0.3
a Rmerge hkl j Ihkl,j 	 Ihkl 
 /hkl j Ihkl,j.
b Rfactor hklFo Fc/hklFo for all data excluding the 5% that comprised the
Rfree used for cross-validation.
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Although the Ly49Cconfiguration is clearly open, the precise
domain juxtapositioning differs by a rotation of 9° from that
observed in the unliganded and H-2Kb bound forms of Ly49C,
such that the atoms on the outer surface of the homo-dimer are
translated by up to6.5 Å (Fig. 4B). This effect is magnified at
the level of the H2-Q10 molecule, which is translated by up to
13 Å at the N terminus of the 1 helix when compared with the
Ly49CH-2Kb structure (Fig. 4C). Thus, it may be that H2-Q10
binding, but not the H-2Kb interaction, triggers a change in
configuration of the Ly49 homo-dimer. However, we cannot
exclude the possibility that the observed differences are due to
inherent plasticity at the Ly49 homo-dimer interface.
The Ly49CH2-Q10 Interface—Each Ly49C monomer inter-
acts with a broad region of the H2-Q10 molecule, burying a
total solvent-accessible surface area of 2,200 Å2. Of this, 50% is
accounted for by Ly49C, 39% is derived from theH2-Q10 heavy
chain, and the remaining 11% is attributed to the 2M subunit.
The total buried surface area is less than that observed for
Ly49CH-2Kb (2,400 Å2) and Ly49AH-2Dd (2,800 Å2). Overall,
the Ly49CH2-Q10 interface is polar in nature, comprising 13
H-bonds and 9 salt bridges (Table 2), and is characterized by
good charge complementarity (Fig. 5). Although the H2-Q10
surface is primarily electronegative and the Ly49C surface is
overwhelmingly electropositive, most of the ionic interactions
at the interface are attributed to a narrow negatively charged
strip that runs down the Ly49C surface and comprises Glu-241,
Asp-242, and Asp-244. Together, these residues form a net-
work of salt bridges with an electropositive region of the
MHC-Ib that includes residues from both the H2-Q10 heavy
chain (Arg-111 and Lys-243) and the 2M subunit (Lys-58)
(Fig. 5).
The majority of the contacts at the Ly49CH2-Q10 interface
are derived from the Ly49C L3 and L5 loops as well as the
4-strand. In particular, Glu-241 from the 4-strand lies at the
heart of the interface and provides a central focal point for a
triad of residues from the H2-Q10 heavy chain (Arg-111 and
Gln-115) and 2M subunit (Lys-58) (Fig. 6). Adjacent to Glu-
241 lies another prominent residue, Arg-239 from the L5 loop,
which inserts into the H2-Q10/2M juncture, forming an
extensive network of both polar and non-polar interactions
with Asp-122 and Gln-115 fromH2-Q10 and themain chain of
Lys-58 from the 2M subunit. These central, predominantly
polar interactions are supplemented by a number of additional
contacts derived from the L5 loop (Ser-236, Lys-237, and Ala-
FIGURE 2. Structure of unliganded H2-Q10. A, overview of the unliganded H2-Q10 (VGITNVDL) complex. The heavy chain is shown in violet, 2M is in cyan,
and the VGITNVDL peptide is in green. B, the conformation of the bound peptide (stick representation). The corresponding 2Fo Fc electron density is shown
inmesh format contoured at 1.C, top view showing interactionsbetween theH2-Q10heavy chain (violet) and theboundpeptide (green sticks).D, interactions
of each peptide anchor position with H2-Q10. Hydrogen bonds are represented by dashed lines. E, comparison of the peptide-binding groove of H2-Q10 with
other MHC-Ia (H2-Kb) and MHC-Ib (Qa-1b). Pocket positions of H2-Q10 are labeled.
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FIGURE 3.Overview of the Ly49C H2-Q10 complex. A, the 2Fo Fc electron density map is shown contoured at 1 and colored according to chain (H2-Q10
(violet); 2M (cyan); Ly49C (magenta)). B, the Ly49C.H2-Q10 complex visible within the crystallographic asymmetric unit is shown in ribbon representation.
Within the Ly49C homo-dimer (magenta), each Ly49C monomer interacts with one H2-Q10 molecule (H2-Q10 violet; 2m (cyan)).
FIGURE4.Variations inLy49configuration.A, the configurationof theLy49homo-dimer fromthe following structures is shown in ribbon representationwith
the -helices in red and in two different orientations: Ly49CH2-Q10 (left), Ly49CH-2Kb (middle), and Ly49AH2-Dd (right). B, overlay of the Ly49C homo-dimer
in the H2-Q10 bound (magenta) and H2-Kb bound (gray) states showing the relative difference in domain juxtapositioning. Themolecules were aligned based
on the left-hand sidemonomer. C, the same structural alignment as described in B, but in this case, only theMHC-I are shown. The peptides are shown as sticks
in green (Ly49CH2-Q10) or black (Ly49CH-2Kb).
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238) that are primarily non-polar in nature with the exception
of a hydrogen bond from the hydroxyl group of Ser-236 to Asp-
122 ofH2-Q10. In contrast to the interactions with theH2-Q10
1/2 domain and the 2M subunit, the interface between
Ly49C and the H2-Q10 3 domain is markedly less well
defined, both in the current structure and in the 2.9 Å resolu-
tion structure of Ly49CH-2Kb (Protein Data Bank (PDB) ID:
3C8K) (34). In particular, the electron density for some of the
larger Ly49C side chain residues (e.g. Lys-203 and Arg-230) is
poorly defined, suggesting that these residues may be flexible
and not contribute significantly to the interaction.
Comparison with Ly49CH-2Kb Structure—Overall, the
docking mode of H2-Q10 on Ly49C is highly similar to that of
H-2Kb (r.m.s.d 0.89 Å over 470 C atoms, based on alignment
of one Ly49C monomer with one H2-Q10/H-2Kb molecule).
Moreover, the interactions at the Ly49CH2-Q10 interfacemir-
ror those found within the Ly49CH-2Kb complex, further
emphasizing the conserved nature of these related MHC mol-
ecules (Fig. 7A).
Although similar, a comparison of the Ly49CH2-Q10 and
Ly49CH-2Kb binding footprint suggests that the Ly49C con-
tacts with the 1/2 chains and the 2M subunit are particu-
TABLE 2
Comparison between Ly49CH2-Q10 and Ly49CH-2Kb contacts
Atomic contacts for the Ly49CH2-Q10 structure were determined with the CCP4i implementation of CONTACT and are shown alongside those previously reported for
the Ly49CH-2Kb structure (34) (PDB ID: 3C8K). van der Waals interactions were defined as non-hydrogen bond contact distances of 4 Å or less. Hydrogen-bond
interactions were defined as contact distances of 3.4 Å or less. Only amino acid residues that are well defined in electron density are included.
Ly49CH2-Q10 Ly49CH-2Kb
TypeLy49C H2-Q10 2M Ly49C H2-Kb 2m
Lys-157 Lys-3 VDW
Ser-161 Gln-226 Ser-161 Ile-225 VDW
Pro-192 Arg-121 Pro-192 Cys-121 VDW
Asn-194 Asp-59 Asn-194 Asp-59 VDW
Asn-194 Lys-3 VDW
Lys-221 Glu-128 VDW
Lys-221 Glu-128 Lys-221 Glu-128 H-bond
Lys-224 Arg-111 VDW
Lys-224 Glu-128 VDW
Met-225 Arg-111 Met-225 Arg-111 VDW
Met-225 Glu-128 Met-225 Glu-128 VDW
Asn-226 Lys-102 VDW
Asn-226 Lys-102 H-bond
Asn-226 Leu-110 Asn-226 Leu-110 VDW
Asn-226 Leu-110 H-bond
Phe-227 Lys-102 VDW
Lys-228 Lys-102 Lys-228 Asp-30, Asp-212 VDW
Arg-230 Asp-212, Ile-213 VDW
Arg-230 Asp-212, Ile-213 H-bond
Arg-230 Asp-212 Salt bridge
Ser-236 Asp-122 Ser-236 Asp-122 VDW
Ser-236 Asp-122 Ser-236 Asp-122 H-bond
Lys-237 Asp-122 Lys-237 Asp-122 VDW
Lys-237 Asp-122 H-bond
Lys-237 Ala-136 VDW
Ala-238 Asp-122 Ala-238 Asp-122 VDW
Ala-238 Asp-122 Ala-238 Asp-122 H-bond
Ala-238 Thr-134 Ala-238 Thr-134, Val-135 VDW
Arg-239 Asp-122 Arg-239 Asp-122 H-bond
Arg-239 Ile-98 VDW
Arg-239 Asp-122 Arg-239 Asp-122 VDW
Arg-239 Asp-122 Salt bridge
Arg-239 Gln-115 VDW
Arg-239 Gln-115 Arg-239 Gln-115 H-bond
Arg-239 Ala-125 VDW
Arg-239 Lys-58 Arg-239 Lys-58, Asp-59 VDW
Arg-239 Lys-58 Arg-239 Lys-58 H-bond
Arg-239 Trp-60 Arg-239 Trp-60 VDW
Arg-239 Trp-60 Arg-239 Trp-60 H-bond
Glu-241 Arg-111 Glu-241 Arg-111 VDW
Glu-241 Arg-111 Glu-241 Arg-111 Salt bridge
Glu-241 Lys-58 VDW
Glu-241 Lys-58 Glu-241 Lys-58 Salt bridge
Glu-241 Gln-115 Glu-241 Gln-115 VDW
Glu-241 Gln-115 H-bond
Asp-242 Lys-58 VDW
Asp-242 Lys-58 Asp-242 Lys-58 Salt bridge
Ile-243 Asp-59 Ile-243 Lys-58 VDW
Asp-244 Lys-243 Salt bridge
Asn-246 Leu-230 Asn-246 Leu-230, Val-231 VDW
Asn-246 Leu-230 Asn-246 Leu-230 H-bond
Asn-246 Glu-232 Asn-246 Glu-232 VDW
Ile-247 Glu-232 Ile-247 Gln-29 VDW
Ile-247 Gln-29 VDW
Pro-248 Gln-29 Pro-248 Gln-29 VDW
Tyr-249 Asp-59 Tyr-249 Asp-59 VDW
Tyr-249 Asp-59 Tyr-249 Asp-59 H-bond
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larly well conserved (Fig. 7A). For example, of the nine contact
residues within the H2-Q10 1/2 region, seven are absolutely
conserved and make similar interactions in the Ly49CH-2Kb
structure, one (Arg-121) differs in sequence (Cys-121 inH-2Kb)
but maintains a contact with Ly49C, and only one (Asp-30)
does not contact Ly49C. Notably, these conserved interactions
include residues from the Ly49C 4-strand and L5 loop that, as
discussed above, are centrally located at the heart of the
Ly49CH2-Q10 interface. By comparison, the physio-chemical
properties of Qa-1b in this region differ substantially, with
changes in amino acid charge (e.g. K102D and R121Q) and
hydrophobicity (e.g. A125S and A136N) (Fig. 1A) providing a
basis for the inability of this related MHC-Ib to bind to Ly49C.
The Ly49C footprint on H2-Q10 is however substantially dif-
ferent from that of H-2Kb within the 3 region, where there are
sequence differences in a number of contact residues including
212, 213, and 225 (Fig. 7A).
Comparison of the Energetic Footprint of Ly49C onH-2Kb and
H2-Q10—Structural analysis indicated that the footprints of
H-2Kb and H2-Q10 on Ly49C are largely overlapping, and our
biophysical data indicated thatH2-Q10 boundwith only amar-
ginally lower affinity. Hence we sought to assess whether the
energetic footprints of both ligands on Ly49Cwere also similar.
We generated 14 Ly49C transfectants that contained single site
mutations at residues directly involved in interactions with
H-2Kb and analyzed binding of either H-2Kb or H2-Q10
tetramers by flow cytometry. The data showed that that the
energetic footprints ofH-2Kb andH2-Q10 on Ly49C are largely
overlapping, correlating well with the structural analysis. Nota-
bly, mutation of Ly49C residues located at the binding interface
(Glu-241, Ser-236, Lys-237, Ala-238, and Arg-239) severely
impacted H2-Q10 and H-2Kb binding to 50% of wild type
(Fig. 7B), suggesting that this region represents the major ener-
getic driving force for both interactions (Fig. 7C). Furthermore,
mutation of Ly49C residues involved in differential contacts in
the 3 region between H-2Kb and H2-Q10 (Lys-203 and Arg-
230) had little effect on binding of either tetramer (Fig. 7A).
Accordingly, although some differences exist at the Ly49C-3
interface, these can be well tolerated as this region contributes
little to the binding energy of the interaction. Therefore, in
conclusion, our data demonstrate that Ly49C has an equivalent
structural and energetic footprint on H-2Kb and H2-Q10.
These data add great credence to the notion that H2-Q10 rep-
resents a genuine ligand for Ly49C.
Discussion
The control ofmurineNK cells through ligation of the inhib-
itory Ly49 receptors has typically been composed of interac-
tions with classical MHC-Ia ligands. Previously, we had shown
that the highly conserved MHC-Ib, H2-M3, interacts with the
NKcell receptor Ly49A (24).Herewe find thatH2-Q10binds to
Ly49C, likely expanding the role of MHC-Ib in regulating
murine NK cell responses. Our data also provide the first struc-
ture of unliganded H2-Q10, as well as the first structure of a
murine NK cell receptor with an MHC-Ib ligand.
To date, the unliganded structures of several MHC-Ib have
been described, including human HLA-E (29, 30) and HLA-G
(35), and murine Qa-1b (27), Qa-2 (Q9 (36)), and H2-M3 (28).
At a population level, the limited polymorphism in MHC-Ib
means that they present a more limited peptide repertoire than
the class Ia counterparts. However, the nature of the peptide-
binding groove itself further limits the repertoire in many
instances. For example, although there are structural differ-
ences within the peptide-binding grooves of HLA-E andQa-1b,
both molecules harbor five anchor positions, serving to effec-
tively restrict the number of peptides that can be accommo-
FIGURE 5. The molecular surface at the Ly49CH2-Q10 interface. Electro-
static complementarity at the Ly49CH2-Q10 interface is shown. Positive sur-
faces of Ly49C (left) and H2-Q10 (right) are shown in red (5 kiloteslas), neu-
tral surfaces are in white (0 kiloteslas), and negative surfaces in blue (5
kiloteslas). Charge potentials were calculated with APBS (42) and are visual-
ized in PYMOL. Amino acid residues that form salt bridges between Ly49C
and H2-Q10 are labeled.
FIGURE6.Molecular interactionat theLy49CH2-Q10 interface. The interactions of Ly49C (magenta)with theH2-Q101/2domain (violet) (A) and the2M
subunit (cyan) (B) are shown. For comparison, the equivalent side chain residues in the Ly49CH-2Kb structure (PDB ID: 3C8K) are overlaid in pink (for Ly49C),
green (for the H2-Kb heavy chain), and gray (for the 2M subunit). Hydrogen bonds and salt-bridge interactions are represented by black and red dashed lines,
respectively, and are shown only for the Ly49CH2-Q10 structure.
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dated. In contrast, H2-M3 and Q9 show only one and two
anchor sites, respectively, but at rather unusual positions,
namely at P1 in H2-M3 and at P7 and P9 in Q9. Although
HLA-G possesses five anchor sites, it has a peptide binding
repertoire that is less restricted thanHLA-E.Curiously, we have
shown a similar situation in theH2-Q10 peptide-binding grove,
which also showed five anchor positions at P2-Gly, P3-Ile,
P5-Asn, P6-Val, and P8-Leu. Interestingly, HLA-Gmay serve a
highly specialized role at the fetal/maternal interface (17). It is
possible that H2-Q10 shares an analogous role in controlling
liver NK cell function.
Our data indicate that the mode of binding of Ly49C to clas-
sical (H-2Kb) and non-classical (H2-Q10) MHC is largely con-
served. The key features that allow binding to both molecules,
namely extensive contacts in the 1/2 region and the lack of
peptide contact, could potentially permit the interaction of
Ly49C with a wide range of MHC-I. The residues of Ly49C
involved in binding the H2-Q10 heavy chain are highly con-
served across mouse strains (Fig. 7D), with 14/16 amino acids
conserved between C57BL/6, BALB/c, and NZB strains. Fur-
thermore, position 228, which is a Lys in C57BL/6 and a Thr in
NZB Ly49C, did not contribute energetically to the interaction
FIGURE 7. Comparison of the structure of H2-Q10 and H-2Kb on Ly49C. A, comparison of the binding footprint on H2-Q10/H2-Kb (left) and Ly49C (right).
Contacting surface residues unique to Ly49CH2-Q10 and Ly49CH-2Kb are shown in red and yellow, respectively. Surface contacts that are conserved in both
Ly49C interfaces with H2-Q10 and H2-Kb are colored orange. B, comparison of the energetic footprint of Ly49C on H-2Kb and H2-Q10. Full-length C57/BL6
Ly49C-FLAGwasmutated to Ala (or Gly were an Ala was present) at residues known to bind H-2Kb, andwild-type ormutant Ly49Cwas transiently transfected
into HEK-293T cells. Tetramers of H2-Q10-TGTETLYF (Q10 TGT), H-2Kb-SIINFEKL (Kb OVA), and HLA-E-VMAPRTLIL were used to stain transfected 293T together
with an anti-FLAG mAb and analyzed by flow cytometry. Results show tetramer binding (percentage of tetramer-positive, FLAG-positive (% Tetramer FLAG)
of 3 independent transfectionsnormalized tobindingofwild-typeLy49C (showingmeansS.E.)C, energetichotspot for Ly49Cbinding toH2-Q10. The surface
of Ly49C is shown in purple with residues that severely (50% of wild type), moderately (between 50 and 70% of wild type), or do not (between 70 and
100% of wild type) impact H2-Q10 binding shown in red, orange, and gray, respectively. The view shown is looking down from the top of the H2-Q10
peptide-binding platform. D, sequence alignment of Ly49 receptors from different mouse strains. Dots indicate conserved residues. Conservation of residues
between Ly49s is shown on a scale, whereby residues that are shared between all Ly49s are unmarked and themost variable residues are shown in dark gray.
Asterisks indicate residues of C57BL/6 Ly49C that interact with the H2-Q10 heavy chain (black) or 2M (gray) as determined by crystallographic analysis.
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with H2-Q10. The other different amino acid (position 247,
which is an Ile in C57BL/6 and a Thr in NZB Ly49C)made only
non-polar interactions with Glu-232 of H2-Q10 and is not con-
served in the H-2KbLy49C interface. Hence Ly49C position
247 is unlikely to be critical to the interaction with the MHC-I
heavy chain. Interestingly, the same amino acids at positions
228 and 247 (a Thr in both cases) are shared between NZB
Ly49C andC57BL/6 Ly49H, yet our tetramer binding data indi-
cate that C57BL/6 Ly49H does not interact with H2-Q10 (Fig.
1). However, C57BL/6 Ly49H also differs from Ly49C at posi-
tion 192, where this is a Pro in Ly49C and a Leu in Ly49H.
Intriguingly, Pro-192 made a significant contribution to the
binding energy between Ly49C and H2-Q10, with mutation of
this residue resulting in an 50% loss of tetramer binding.
Therefore, Pro-192 in Ly49C may be important in allowing
H2-Q10 to bind to Ly49C,whereas Leu in this position prevents
H2-Q10 frombinding to Ly49H.These observations emphasize
the impact that even fine molecular alterations can have on
Ly49 receptor-ligand specificity. Furthermore, it is not imme-
diately apparent why H2-Q10 does not bind to Ly49I, as all of
the residues that contact the H2-Q10 heavy chain are con-
served between Ly49C and Ly49I, although there are some
minor differences in residues that contact the2M subunit (e.g.
the substitution of Arg-194 in Ly49C to Ser and of Ile-243 in
Ly49C to Thr). Curiously, previous studies investigating Ly49I
report only very weak interactions with MHC (9). It is possible
that these minor differences in the residues that contact 2M
prevent the interaction of Ly49I withMHCor alternatively that
Ly49I has a completely different mode of binding, such as that
seen between Ly49H and m157 (37).
In contrast, only 8/16 amino acids of Ly49C that bind
H2-Q10 are conserved with C57BL/6 Ly49A. Furthermore, five
of these amino acids made significant energetic contributions
to the interaction between Ly49C and H2-Q10 (Pro-192, Lys-
221, Met-225, Ala-238, and Glu-241), most likely accounting
for the inability of H2-Q10 to interact with Ly49A. Taken
together, our results indicate that H2-Q10 can specifically
interact with the Ly49C receptor, and this interaction is most
likely conserved between different alleles of Ly49C.
Previously, studies on the role of MHC-Ib in the control of
murine NK cells have been almost exclusively limited to the
interaction ofCD94-NKG2 receptorswithQa-1b. Interestingly,
we observed that Qa-1b tetramers do not bind to Ly49C-ex-
pressing CHO cells. Given our structural analysis of the foot-
print of Ly49C on H-2Kb and H2-Q10, it is likely that differ-
ences in the 2 region between Qa-1b and H2-Q10/H-2Kbmay
account for this finding. For example, Ala-125 and Ala-136 in
H2-Q10/H-2Kb both interact with energetically critical resi-
dues of Ly49C (Arg-239 and Lys-237, respectively) and are not
conserved in the Qa-1b sequence (residues Ser-125 and Asn-
136). It is tempting to speculate that functionally analogous
systems exist in mice and humans, whereby the CD94-NKG2
receptors exclusively bind HLA-E/Qa-1b, whereas Ly49/KIR
bind a more diverse but structurally related group of molecules
extending into non-classical MHC ligands. It is interesting to
note recent evidence suggests that the MHC-Ib HLA-F is a
ligand for KIR3DL2 and KIR2DS4 (38). It is also possible that
unlikeMHC-Ia, where the need to present diverse peptide rep-
ertoires forT cell recognition has driven the acquisition of poly-
morphism, the capacity of a number ofMHC-Ib to interactwith
immunoreceptors such as those of the Ly49 family may have
served to limit their genetic diversification.
Although we have identified a role for H2-Q10 in NK cell
interactions, our data do not necessarily preclude a function for
this molecule in mediating other immune responses. Previous
peptide elution and substitution experiments have identified
that H2-Q10 binds a heterogeneous repertoire of peptides with
a preference for Gly at P2, Leu/Val at P6, and Phe/Leu at P
(22). Accordingly, the H2-Q10 peptide-binding groove is con-
sidered to resemble that of MHC-Ia rather than of other more
specializedMHC-Ib such as Qa-1b, H2-M3, or HLA-E. Overall,
the unliganded H2-Q10 structure supports this proposition,
and in addition, peptide residues P4-Thr, P6-Val, and P7-Asp
are solvent-exposed and thus could represent candidate T cell
receptor contact sites. Secretion of H2-Q10 was down-regu-
lated following liver injury (20), perhaps suggesting that this
molecule plays a role in mediating NK or T cell responses fol-
lowing cellular stress. Indeed, the biology, regulation, and pre-
cise function of this unusual MHC molecule require further
investigation.
Experimental Procedures
Mice—C57BL/6 and H-2KbDb knock-out (39) mice were
from the Department of Microbiology, University of Mel-
bourne. All mice used were 6–10 weeks of age. All experiments
were performed in accordance with the animal ethics guide-
lines of the National Health and Medical Research Council of
Australia. All experiments were approved by the University of
Melbourne Animal Ethics Committee.
Flow Cytometry—For NK cells, spleens were collected from
wild-type and H-2Kb/Db-deficient mice and red blood cells
removed using ACK (ammonium-chloride-potassium) lysing
buffer. Nonspecific receptors were then blocked with 2.4G2
antibody. Cells (5  106) were stained with NK1.1 (PK136;
eBioscience), CD3 (17A2; BioLegend), H2-Q10 and HLA-E
tetramers prior to fixation with 2% paraformaldehyde. Follow-
ing washing, 5 103NK cell (NK1.1/CD3) events were elec-
tronically collected using an LSR-II (BD Biosciences).
For CHO cells expressing Ly49, cells were cultured for 1 day
at a density of 2  105 cells/ml and removed from the tissue
culture plastic with 50 mM EDTA. Following blockade of non-
specific binding by 2.4G2 antibody, cells were stainedwith anti-
body to Ly49 or H2-Q10 tetramers. Following fixation with 2%
paraformaldehyde and subsequent washing, 5  104 events
were electronically collected using an LSR-II or FACSCanto
(BD Biosciences).
Cloning and Expression of Recombinant Proteins—For mam-
malian expression, the entire extracellular domains of Ly49A
and Ly49C (Ly49-EC) fromC57BL/6mice were cloned into the
pHLsec vector downstream of a signal peptide, His tag, and
BirA site, as described previously (24, 37). For expression in
mammalian cells, secreted Ly49-EC produced from transiently
transfected HEK-293T cells was harvested from the culture
medium 3 days after transfection, dialyzed against 10 mM Tris,
pH 8.0, 500 mM NaCl, and purified using nickel affinity resin.
The Ly49-EC was eluted from the nickel resin with 10mMTris,
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pH 8.0, 500 mM NaCl, 500 mM imidazole, and the protein was
purified by gel filtration chromatography using an S200 16/60
column (GE Healthcare).
For bacterial expression, the entire Ly49C EC or lectin-like
domain (starting from Ser-132) was cloned into the pET30 vector
and expressed in BL21 Escherichia coli cells as described previ-
ously (37). Inclusion bodies harboring the Ly49 protein were
resuspended in 6 M guanidine, 0.5 mMNa-EDTA, and 1mMDTT
and refolded by flash dilution in a solution containing 100 mM
Tris-HCl (pH 8.0), 400 mM L-arginine-HCl, 5 mM reduced gluta-
thione, and 0.5 mM oxidized glutathione. The refolding solution
was then dialyzed against 25 mM HEPES (pH 7.5), followed by
purificationby cation exchange (carboxymethyl and sulphopropyl
resin) and size-exclusion chromatography.
cDNA encoding residues 1–274 of H2-Q10was generated by
GenScript (Piscataway, NJ) and cloned into a pUC57 vector.
H2-Q10 was then subcloned into a pET-30-based vector that
allowed for an in-frame fusion of a substrate peptide for the
enzyme BirA. The H2-Q10, H-2Kb, H-2Dd, Qa-1b, or HLA-E
heavy chains andmurine2-microglobulinwere expressed sep-
arately in E. coli, purified from inclusion bodies, and refolded in
the presence of either TCRV chain (TGTETLYF) or ribophorin
(VGITNVDL) peptides forH2-Q10,OVA (SIINFEKL) forH-2Kb,
motif peptide (AGPARAAAL) for H-2Dd, QDM (AMAP-
RTLLL) for Qa-1b, or VMAPRTLIL for HLA-E and purified
essentially as described previously (40).
Surface Plasmon Resonance—A ProteOn XPR36 protein
interaction array system (Bio-Rad) was used for surface plas-
mon resonance (SPR) as described (24). An NLC (NeutrAvidin
coated sensor chip, Bio-Rad) was used to capture 300
response units of biotinylated H2-Q10-TGTETLYF, H-2Kb
SIINFEKL, H-2Dd-AGPARAAAL, and HLA-E-VMAPRTLIL.
An empty flow cell containing NeutrAvidin alone served as a
control surface. Serially diluted (30–0.8 M) Ly49A or Ly49C
was injected over test and control surfaces at a rate of 100
l/min for 60 s. After subtraction of the response from the
control flow cell, KD was measured by non-linear regression at
equilibrium using Prism (GraphPad) and ProteOn Manager
software (version 3.0.1). All interactions were tested minimally
in duplicate.
Crystallization, Data Collection, Structure Determination,
and Refinement—All crystals were obtained at 20 °C using the
hanging drop vapor diffusion method. Unliganded H2-Q10 in
complex with a ribophorin peptide (VGITNVDL, VGI) was
crystallized at 6.8 mg/ml from a solution containing 8% PEG
3350, 0.1 M sodium malonate, pH 5.0, and 0.01 M -nicotina-
mide adenine dinucleotide hydrate. For Ly49CH2-Q10-VGI,
individual proteins weremixed in a 1 Ly49 dimer/2 H2-Q10VGI
molar ratio at a total protein concentration of 6.8 mg/ml and
crystallized froma solution containing 12%PEG8000, 10%PEG
400, 0.1 M HEPES, pH 7.2, and 0.2 M NaCl. Prior to data collec-
tion, crystals were equilibrated in a crystallization solution sup-
plemented with 30% PEG 3350 (H2-Q10VGI) or 20% PEG 8000
(Ly49CH2-Q10VGI) for cryoprotection. Crystals were flash-
cooled using liquid nitrogen, and x-ray diffraction data were
recorded on a Quantum-315 CCD detector at the MX1 (H2-
Q10-VGI) or MX2 (Ly49CH2-Q10VGI) beamlines of the Aus-
tralian Synchrotron. Data were integrated usingMOSFLM and
scaled using SCALA from the CCP4 program suite.
The first unliganded crystal structure of H2-Q10VGI was
resolved to 2.3Åbymolecular replacement using PHASERwith
a search model comprising the heavy chain and 2M subunit
fromH-2Db (PDB code 1YN6). Following subsequent rounds of
model building in COOT and refinement using Buster, the
completed structure comprised residues 1–276 of H2-Q10,
1–99 of 2M, and 1–8 of the peptide and refined to an Rfactor/
Rfree of 17.7/24.7. The 3.3 Å structure of the Ly49CH2-Q10VGI
complexwas also determined by PHASERusing the unliganded
H2-Q10VGI structure (described above) and the lectin domain
of Ly49C (PDB code 3C8J) as search models. The asymmetric
unit comprised two molecules of H2-Q10VGI and two Ly49C
monomers. The contents of the asymmetric unit were reorga-
nized using the ACHESYM algorithm (41), revealing that the
Ly49C monomers formed a dimer. Thus, the entire complex
was composed of one Ly49C dimer and two molecules of
H2-Q10VGI. Following refinement using Buster, the completed
structure comprised residues 1–277 of H2-Q10, 1–99 of 2M,
1–8 of the peptide, and 141–262 of Ly49C. Details of the data
processing and refinement statistics are given in Table 1.
Mutagenesis—cDNA encoding entire C57/BL6 Ly49C fused
to a C-terminal FLAG motif was generated by GenScript and
cloned into a pMIG plasmid for transient transfection into
HEK-293T cells. Site-directed mutants of Ly49C were gener-
ated by the QuikChange Site-Directed Mutagenesis Kit (Strat-
agene, La Jolla, CA), and the sequence of the mutated cDNA
was verified by DNA sequencing. The residues chosen for
mutagenesis were chosen by structural analysis of the Ly49H-
2Kb complex (34) andweremutated toAla (orGlywhere anAla
was present). Wild-type or mutant Ly49C pMIG constructs
were transiently transfected into HEK-293T (FuGENE), and
expression of Ly49C was confirmed by an antibody to FLAG
and/or Ly49C. Biotinylated monomers of H2-Q10-TGTETLYF,
H-2Kb-SIINFEKL, and HLA-E-VMAPRTLIL were conjugated
with streptavidin-phycoerythrin and used to stain transfected
293T together with the anti-FLAG mAb and analyzed by flow
cytometry. Results were analyzed by FlowJo (TreeStar).
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